Literature DB >> 21117129

A modified family-B archaeal DNA polymerase with reverse transcriptase activity.

Stanislaw K Jozwiakowski1, Bernard A Connolly.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 21117129     DOI: 10.1002/cbic.201000640

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


× No keyword cloud information.
  6 in total

Review 1.  Primase-polymerases are a functionally diverse superfamily of replication and repair enzymes.

Authors:  Thomas A Guilliam; Benjamin A Keen; Nigel C Brissett; Aidan J Doherty
Journal:  Nucleic Acids Res       Date:  2015-06-24       Impact factor: 16.971

2.  A highly divergent archaeo-eukaryotic primase from the Thermococcus nautilus plasmid, pTN2.

Authors:  Sukhvinder Gill; Mart Krupovic; Nicole Desnoues; Pierre Béguin; Guennadi Sezonov; Patrick Forterre
Journal:  Nucleic Acids Res       Date:  2014-01-20       Impact factor: 16.971

3.  An archaeal family-B DNA polymerase variant able to replicate past DNA damage: occurrence of replicative and translesion synthesis polymerases within the B family.

Authors:  Stanislaw K Jozwiakowski; Brian J Keith; Louise Gilroy; Aidan J Doherty; Bernard A Connolly
Journal:  Nucleic Acids Res       Date:  2014-07-24       Impact factor: 16.971

4.  PPL2 translesion polymerase is essential for the completion of chromosomal DNA replication in the African trypanosome.

Authors:  Sean G Rudd; Lucy Glover; Stanislaw K Jozwiakowski; David Horn; Aidan J Doherty
Journal:  Mol Cell       Date:  2013-11-21       Impact factor: 19.328

5.  Stimulation of reverse transcriptase generated cDNAs with specific indels by template RNA structure: retrotransposon, dNTP balance, RT-reagent usage.

Authors:  Christophe Penno; Romika Kumari; Pavel V Baranov; Douwe van Sinderen; John F Atkins
Journal:  Nucleic Acids Res       Date:  2017-09-29       Impact factor: 16.971

Review 6.  Alteration of enzymes and their application to nucleic acid amplification (Review).

Authors:  Kiyoshi Yasukawa; Itaru Yanagihara; Shinsuke Fujiwara
Journal:  Int J Mol Med       Date:  2020-09-15       Impact factor: 4.101

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.